Related Experiment Video
Updated: Apr 27, 2026
09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
Genomic characterization of acute leukemias
Sabina Chiaretti1, Valentina Gianfelici, Giulia Ceglie
1Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
Summary
Recent advancements in molecular technologies have refined understanding of leukemia development and improved patient stratification for acute myeloid and lymphoblastic leukemias. These findings pave the way for personalized cancer medicine.
Area of Science:
- Oncohematology
- Molecular Biology
- Genomics
Background:
- Hematologic malignancies have seen significant technological advancements over the last 20 years.
- Powerful technologies like next-generation sequencing have refined understanding of leukemic transformation.
- These advancements aid in developing novel prognostic algorithms for patient stratification.
Purpose of the Study:
- To review novel molecular findings in acute lymphoblastic leukemia (B and T lineage) and de novo acute myeloid leukemia.
- To highlight the impact of new technologies on understanding these hematologic malignancies.
- To discuss the implications for personalized and targeted medicine in leukemia treatment.
Main Methods:
- Review of recent literature on hematologic malignancy research.
- Analysis of data from technologies including conventional karyotyping, FISH, gene/microRNA expression profiling, array CGH, SNP arrays, and next-generation sequencing (WES, RNA-seq).
- Synthesis of findings related to leukemic transformation mechanisms and prognostic markers.
Main Results:
- Refined understanding of the mechanisms underlying leukemic transformation.
- Development of novel prognostic algorithms for improved patient stratification at diagnosis.
- Identification of specific molecular markers crucial for targeted therapy.
Conclusions:
- Technological advancements have significantly improved the diagnosis and understanding of acute leukemias.
- Molecular profiling enables personalized medicine approaches for leukemia patients.
- Future research directions focus on leveraging these markers for tailored treatment strategies.
